Glomerular disease often features altered histologic patterns of extracellular matrix (ECM). Despite this, the potential complexities of the glomerular ECM in both health and disease are poorly understood. To explore whether genetic background and sex determine glomerular ECM composition, we investigated two mouse strains, FVB and B6, using RNA microarrays of isolated glomeruli combined with proteomic glomerular ECM analyses. These studies, undertaken in healthy young adult animals, revealed unique strain-and sexdependent glomerular ECM signatures, which correlated with variations in levels of albuminuria and known predisposition to progressive nephropathy. Among the variation, we observed changes in netrin 4, fibroblast growth factor 2, tenascin C, collagen 1, meprin 1-a, and meprin 1-b. Differences in protein abundance were validated by quantitative immunohistochemistry and Western blot analysis, and the collective differences were not explained by mutations in known ECM or glomerular disease genes. Within the distinct signatures, we discovered a core set of structural ECM proteins that form multiple protein-protein interactions and are conserved from mouse to man. Furthermore, we found striking ultrastructural changes in glomerular basement membranes in FVB mice. Pathway analysis of merged transcriptomic and proteomic datasets identified potential ECM regulatory pathways involving inhibition of matrix metalloproteases, liver X receptor/retinoid X receptor, nuclear factor erythroid 2-related factor 2, notch, and cyclin-dependent kinase 5. These pathways may therefore alter ECM and confer susceptibility to disease.
Extracellular matrix (ECM) is a complex niche of structural and regulatory proteins that provide the supporting scaffold for cells. In addition to the loose networks of ECM surrounding all cells, basement membranes (BMs) represent the condensed networks of ECM, which underlie all epithelial sheets. ECM determines tissue rigidity, 1 has roles in cell signaling, [2] [3] [4] is critical for tissue development 5, 6 and is implicated in genetic and acquired diseases. [7] [8] [9] [10] Proteomic approaches are being pursued for global analyses of the complex niche represented by ECM [11] [12] [13] and such studies are beginning to help unravel ECM roles in health and disease. 14, 15 Glomerular disease often features altered histologic patterns of ECM. Candidate-based investigations of glomerular ECM demonstrate the presence of tissue-restricted isoforms of collagen IV 16 and laminin, 17 and mutations of genes encoding these proteins cause glomerular disease. 18 Dysregulated glomerular ECM is only understood at a rudimentary level although there is potential for therapeutic targeting. 18 We recently exploited mass spectrometry (MS)-based proteomics to characterize healthy human glomerular ECM in an unbiased manner, 19 identifying 144 proteins, demonstrating the complexity of this niche. Furthermore, we identified a core of highly connected ECM proteins which may be required for BM assembly. 20 Alongside ECM changes, glomerular disease features loss of barrier integrity manifest as increased albuminuria. In overtly healthy human populations, albuminuria varies with racial background 21, 22 and sex. 23, 24 This is recapitulated in inbred mouse strains: for example, young adult FVB mice have 8-fold greater albuminuria than B6 mice 25 and within each of these strains, males have 2-fold greater albuminuria than females. 25 The albuminuria range between female B6 and male FVB mice corresponds, after factoring for weight, to human albuminuria of 30-300 mg/day. Notably, there are no significant differences in systemic blood pressure between FVB and B6 mice but the former have significantly fewer glomeruli/kidney. 25 Furthermore, FVB mice have more severe disease than B6 mice in nephropathy models. 26, 27 In this investigation, we tested the hypotheses that genetic background and sex influence glomerular ECM and that ECM composition relates to the degree of albuminuria. We investigated B6 and FVB mouse strains using RNA microarrays of isolated glomeruli combined with proteomic analyses of glomerular ECM and we examined ECM structure with electron microscopy (EM).
RESULTS

RNA Profiling
We undertook principal component analysis (PCA) of all detected transcripts in microarrays from glomeruli isolated from B6 and FVB mice. 25 The determinants of sample variation were strain and sex (PC-1: 94.4%; PC-2: 3.6% of the total variation) (Supplemental Figure 1A) . Using gene ontology (GO) classification, the subset of ECM transcripts was selected and a further PCA revealed that the strains could still be distinguished, (PC-1, 91.6%; PC-2, 6.3% of the total variation) but there was less variation between sexes (Supplemental Figure 1A) . Similar separation was observed using unsupervised hierarchical clustering (Supplemental Figure 1B) where the ECM transcript data segregated into clusters relating to strains and within the strains, sexes clustered together. Upregulated gene clusters were categorized by GO enrichment analysis (Supplemental Table 1 ) and the top five enriched terms were annotated onto the clustered heat map (Supplemental Figure 1B) . This revealed enrichment of neuronal development and peptidase inhibitor activity in FVB glomeruli. Conversely, GO ECM terms, including adhesion and receptor binding, were enriched to B6 glomeruli. Thus, the glomerular transcriptome, including ECM transcripts, is influenced by strain and, to a lesser extent, by sex.
ECM Enrichment
To analyze glomerular ECM using proteomics we developed a workflow for ECM isolation, adapted from our human glomerular studies 19 (Supplemental Figure 2A) . We harvested mouse glomeruli using Dynabead perfusion 25 and this approach yielded significantly more glomeruli/kidney versus sieving (Supplemental Figure 2B ). Glomeruli were fractionated to produce an enriched ECM fraction ( Figure 1A , Supplemental Figure 2A ) and enrichment was confirmed by GO analysis of MS identifications ( Figure 1B ). Western blotting also confirmed enrichment with increased laminin and collagen IV but reduced cellular proteins in the ECM fraction ( Figure 1C ).
ECM Proteomes
Triplicate enriched ECM fractions from the four groups (i.e., FVB and B6 male and females) were analyzed by MS. Identified proteins were classified as ECM as previously defined. 19, 20 A combination of the mouse matrisome resource 12 and DAVID GO 28 was used to classify proteins as BM, other structural ECM or ECM-associated (Supplemental Table 2 ). Overall, 115 ECM proteins were identified, consistent with murine colon (106), murine lung (143), human aorta (103), and human glomerular ECM (144), 12, 19, 29 and PCA analyses found the main cause of sample variation was strain (PC-1, 85.6%; PC-2, 4.7% of the total variation) ( Figure 1D ). We compared the ECM proteome with the ECM transcriptome and found a weak, but significant, correlation (r=0.22, P,0.001) (Supplemental Figure 2C ), in keeping with previous studies in skin. 30 The proteomic data were used to generate a glomerular ECM protein-protein interaction network. Most glomerular ECM proteins (58%) were identified in all four groups of mice ( Figure 1E , Supplemental Table 2 ). This common subset of proteins, including all known major glomerular ECM components, formed the most highly connected network, making 92% of reported protein-protein interactions and contained almost all (96%) of the BM and 52% of other structural ECM proteins identified in the dataset. ECM-associated proteins were more peripherally associated with the interaction network ( Figure 2 ). The subset of connected proteins likely represents components essential for glomerular ECM assembly and/or maintenance.
Using topological network analysis of all ECM proteins identified by MS, BM proteins made significantly more interactions than ECM-associated proteins (Supplemental Figure 3A) . Moreover, 60% of BM and other structural ECM proteins were shared in human and mouse datasets (Supplemental Figure 3B ) and the mouse-human shared interactome contained 74% of all protein-protein interactions identified from both datasets, thus emphasizing the overlap between human and mouse glomerular ECM in both composition and network topology.
Enriched ECM Proteins
Globally there were no significant differences in the subtypes of ECM proteins between mouse groups (Supplemental Figure 3 , C-E). Therefore to assess variation in individual proteins we focused on abundant proteins (.5 spectral counts) present in our interaction network ( Figure 2 ). While we did not find significant changes in known GBM components (Figure 3 , A-J), we observed consistent variation in others. Netrin 4 was more abundant (microarray and MS) in FVB versus B6 mice ( Figure 3K ). FGF2 protein was detected in FVB but not B6 (MS), however Fgf2 transcripts were below the microarray detection level ( Figure 3L ). Tenascin C levels (microarray and MS) were highest in B6 females and lowest in FVB males ( Figure 3M ). Alpha-1 and -2 chains of collagen I were more abundant (microarray and MS) in B6 versus FVB ( Figure 3N ) and in both strains, the matrix metalloproteases meprin 1-a and meprin 1-b were more abundant in males than females (Figure 3 , O and P). These candidates were therefore selected for further investigation.
Validation of Candidates and Correlation with Albuminuria
In the main cohort of mice, protein abundance was validated using quantitative immunohistochemistry. Here we found that laminin and collagen IV were equally detected across all four groups whereas FGF2 and netrin 4 were highest in FVB, collagen I and tenascin C were highest in B6 and meprins were highest in males ( Figure  4 , A and B). To determine whether changes in ECM protein abundance correlated with albuminuria, we measured albumin creatinine ratios (ACR) in a second cohort of mice and analyzed candidate ECM proteins in these mice by quantitative Western blot ( Figure 4C , Supplemental Figure 4 ). We found albuminuria at 18 weeks followed the previously reported pattern (B6f, B6m,FVBf,FVBm) 25 ( Figure 5A ) and there was correlation between abundance of candidate ECM proteins and albuminuria. As predicted from the microarray and MS, laminin abundance did not correlate with ACR (r=0.014, P.0.95) ( Figure 5B ). Collagen I had a strong negative correlation (r=20.91, P,0.0001) and tenascin C had a weaker correlation (r=20.47, P=0.027) ( Figure 5C ). In keeping with microarray and MS, collagen I-a 2 was increased in B6 mice (Supplemental Figure 5D ). Only the qRT-PCR of meprin a and b did not follow the pattern of microarray or MS (Supplemental Figure 5 , E and F). Overall these findings validate the selected ECM proteins and demonstrate striking correlation with albuminuria. Nodes are labeled with gene names for clarity. ECM proteins were categorized as BM, other structural ECM or ECM-associated proteins and were colored accordingly. Node diameter is proportional to number of interaction partners (degree). The interaction network was clustered, and topological parameters were computed. Self-interactions were excluded from the analysis. Black arrowheads indicate proteins that were selected for further study.
BM Ultrastructural Variation
Having discovered compositional change in ECM, we proceeded to investigate ECM organization. Transmission EM (TEM) and serial block face scanning EM (SBF-SEM) were used to examine glomerular BMs (GBMs). GBMs were significantly thicker in FVB than B6 mice ( Figure 6A ) although podocyte foot process width was unchanged ( Figure 6B ). The thickened GBM was confirmed with SBF-SEM using 3D reconstructions (Supplemental Movie 1). Moreover, SBF-SEM identified reproducible sub-podocyte regions of thickened and expanded GBM in FVB mice (Figure 6 , C-E, Biologic Pathways Analysis Available exome data from B6 and FVB mice were interrogated for the 4586 genes predicted from the microarray to be influenced by strain (Anova; P,0.01) together with known glomerular genes. No frame-shift, truncation or read-through mutations were found (Supplemental Figure 6) . Because analysis of quantitative trait loci would be a substantial and independent study, 31 we performed GO enrichment and pathway analyses on proteomic and microarray datasets to gain insight into ECM regulatory pathways. Components and GO terms selectively enriched in a strain-dependent manner were hierarchically clustered to produce a heat map and associated dendograms (Supplemental Figure 7A) . In this analysis, the FVB data associated with terms for inflammation, wound healing and cell adhesion, whereas collagen and epithelial development terms associated with the B6 strain. We created a GO enrichment map view for proteins enriched in FVB or B6 and, for each strain, found a single highly clustered network of GO terms, all related to ECM. The only difference in the two clusters was the enrichment of protease inhibitor terms in the FVB cluster (Supplemental Figure 7B) . Using GO enrichment map view for the whole microarray, we found few terms enriched to B6 glomeruli and these included an ECM cluster and terms relating to post-translation modifications ( Figure 7A ). However, FVB glomeruli had many enriched terms ( Figure  7A ). Three clusters relating to peroxisome, fatty acid metabolism and lipid biosynthesis and organelles would be consistent with altered lipid processing. Similarly, clusters relating to coenzyme biosythesis and mitochondrial biologic processes would be consistent with altered mitochondrial biology. Using pathway prediction tools to compare ECM transcripts and ECM proteins, we identified a link from lipid metabolic pathways via LXR/RXR signaling to NRF2 and mTOR signaling pathways, which were predicted to be more active in FVB versus B6 glomeruli ( Figure 7 , B and C). Conversely, notch signaling and CDK5 signaling were predicted to be active in B6 glomeruli (Figure 7 , B and C). In FVB glomeruli, inhibition of matrix metalloproteases was predicted with several approaches (Supplemental Figures 1B, 7 , B and C). Interestingly, metalloproteinase inhibitor 3 (TIMP3) was detected by MS in only FVB animals, but microarray data suggested no difference in expression. Further analysis with qRT-PCR demonstrated that Timp3 levels were significantly increased in FVB males (Figure 7D) . Overall, these analyses reveal potential novel pathways, which may regulate glomerular ECM and confer susceptibility to glomerular disease.
DISCUSSION
Among changes in composition, netrin 4 was enriched in glomerular ECM from FVB mice. Netrin 4 may be involved in BM assembly 32 and epithelial cells adhere to netrin 4 via a1b2 and a3b1 integrins, 33 both of which are expressed by podocytes. However, the regulation of this ECM component and its requirement for GBM assembly has not been examined. FGF2 was also upregulated in FVB datasets and this growth factor, enriched in BMs, has tissue-specific roles including angiogenesis, cell proliferation, survival, migration, and differentiation. 34 FGF2 signals via the FGF receptor tyrosine kinase and FGFR signaling is critical for the growth and patterning of all renal lineages. 34 In the glomerulus, FGF2 is expressed by podocytes and mesangial cells and podocytes lacking FGF signaling fail to rearrange their actin cytoskeleton. 34 Increased FGF2 expression has also been associated with nephropathy models, suggesting that regulation of this pathway requires tight control. 34 Our data support a pathologic role for increased FGF2 signaling in the glomerulus, and suggests it may influence ECM synthesis.
Components enriched to B6, low albuminuria/nephropathyresistant mice included tenascin C and collagen I. Tenascin C is a glycoprotein that modulates the functions of fibronectin 35 and it is involved in neuronal guidance. 36 Collagen I is the predominant structural component of bone and cartilage and a functional role in the glomerulus has yet to be found. Both collagen I and tenascin C are associated with wounding and organ fibrosis, however, our data suggest these proteins may be protective. In our analysis we found few changes related to sex, although protein levels of meprin metalloproteases were enriched to males of both strains. Meprins were originally identified in kidney and intestine and have been shown to have roles in angiogenesis, cancer, inflammation, fibrosis and neurodegenerative disease J software. F, females; M, males. Points represent individual glomerular measurements n.60 from n=3 mice. Box plots indicate 25th and 75th percentiles (lower and upper bounds, respectively), 1.53 interquartile range (whiskers) and median (line). (C) Western blot analysis of glomerular ECM extracts using antibodies to proteins, which were indicated by MS to be altered due to genetic background or sex.
processes. 37 Meprin 1-a and meprin 1-b are unique in their ability to process and release both C-and N-propeptides from type I procollagen, 38 and many other ECM substrates. 39 Our data support a role for these ECM regulatory proteins as sex-associated modifiers of glomerular barrier function.
Having identified changes in ECM composition, we used serial EM sectioning to interrogate structure and we identified GBM defects, which correlated with barrier dysfunction. Abnormal GBM is found across a range of human disease; however, the homogenous expansions we observed were unlike immune-complex deposits. The defects were similar to those seen in mice with global and podocyte-specific deletion of adhesion and matrix proteins, although these phenotypes are often dependent on the genetic background of the mice. 27, 40, 41 We speculate that weakened or split regions of GBM are sensed by podocytes and/or endothelial cells leading to increased synthesis of ECM in an attempt to repair the damage. Alternatively GBM expansions are weak points in the capillary walls susceptible to splitting. We observed these structural changes despite no alterations in known GBM components; collagen IV a-3,4,5 and laminin 521, perlecan, agrin and nidogen 1 and 2. In future studies it would be important to investigate whether changes in netrin 4 or meprins, which were increased in the GBM of FVB and males, respectively, contribute to the structural changes we have observed.
Having identified altered composition and organization of ECM, the question of cause and effect remained. We therefore screened whole exome data from FVB and B6 mice and did not find any mutations in known ECM or glomerular genes. Notably, our previous studies have shown that young adult FVB mice have significantly fewer glomeruli per kidney compared with B6 mice. 25 It has been postulated that congenital nephron deficit predisposes to arterial hypertension and progressive kidney injury 42 ; however, there were no significant differences in systemic arterial pressure between the two adult strains used in this study. 25 It remains possible that altered intraglomerular hemodynamics are present in FVB mice and these contribute to the altered ECM we report. Figure 5 . Correlation of glomerular ECM protein abundance with albumin-to-creatinine ratio. (A) Overnight albumin-to-creatinine ratios were evaluated in 18-week-old adult mice (n=8-10). Data were log transformed before analysis and are presented as geometric means and confidence interval. Statistical significance was determined using a one-way ANOVA followed by least squares difference. There was a significant increase in urinary albumin in male and female FVB mice compared with sex-matched B6 animals. Within each strain, males had elevated albuminuria versus females. (B-H) Correlation of albumin-tocreatinine ratio with abundance of selected glomerular ECM protein candidates detected by Western blot (n=4-6). Correlation analysis was performed using two-tailed Pearson correlation *P,0.05; **P,0.01; ***P,0.001; ****P,0.0001. M, males; F, females. To appreciate regulatory pathways associated with our observations, we performed systems-level analysis. With global microarray data we found enrichment of GO terms relating to mitochondrial dysfunction, activation of NRF2 and lipid metabolism with FVB mice. NRF2 is an antioxidant transcription factor and it increases the expression of ROS detoxification genes, which have been associated with diabetic kidney disease. 43 In the B6 strain, notch signaling was active and this pathway is key for glomerular patterning. 44 In addition, notch intracellular domain expression is increased in glomerular epithelial cells in diabetic nephropathy and in focal segmental glomerulosclerosis. 45, 46 Analysis of the proteomics data predicted CDK5 pathway activity in B6 mice and the Cyclin I-CDK5 complex safeguards podocytes against apoptosis via MAPK signaling. 47 By combining microarray and proteomic data we identified activity of the LXR/RXR pathway with the FVB strain. LXR/RXR are nuclear hormone receptors that act as transcription factors to regulate the expression of genes involved in cholesterol and fatty acid metabolism. 48 In the kidney, LXRs are specifically expressed in renin-producing juxtaglomerular cells and LXRs were shown to regulate renin expression in vivo, suggesting crosstalk between the RAAS and lipid metabolism. 49 Overall our systems-level analysis identified novel pathways, which may lead to changes in ECM and therefore could be the targets of therapeutic intervention to restore glomerular barrier function.
CONCISE METHODS
Antibodies
Monoclonal antibodies used were against actin (clone AC-40; SigmaAldrich-Aldrich, Poole, UK) mtHSP70 (MA3-028; Thermo Fisher Scientific, Waltham, Massachusetts), nidogen (MAB1946; EMD Millipore), tenascin C (MAB2138; R&D Systems), and meprin b (MAB28951; R&D Systems). Polyclonal antibodies used were against lamin B1 (ab16048; Abcam, Inc., Cambridge, UK), pan-collagen IV (ab6586; Abcam, Inc.), pan-laminin (ab11575; Abcam, Inc.), nephrin (ab58968; Abcam, Inc.), fibroblast growth factor 2 (ab106245; Abcam, Inc.), netrin 4 (AF1132; R&D Systems), meprin a (AP5858a; Agent), and collagen I (2150-1410; AbD Serotec). Secondary antibodies conjugated to Alexa Fluor 680 (Life Technologies, Paisley, UK) or IRDye 800 (Rockland Immunochemicals, Gilbertsville, PA) were used for Western blotting. Secondary antibodies conjugated to Alexa Fluor 488 or 594 (Life Technologies) were used for immunohistochemistry.
Mice
C57BL/6JOlaHsd (referred throughout as B6) and FVB/NHanHsd (referred throughout as FVB) mice were used for these experiments and the four experimental groups were B6 female, B6 male, FVB female, and FVB male. n=3 mice per group were used for MS, n=3 mice for microarray, n=3 mice for qRT-PCR, n=3 animals for immunohistochemistry, and n=6 mice for Western blot. For the measurement of albuminuria, urine was collected from 18-week-old mice by housing them individually in metabolic cages for 18 hours. Albumin concentrations were measured by enzyme-linked immunosorbent assay (Bethyl Laboratories, Montgomery, Texas). 25, 50 Urinary creatinine concentrations were assessed by a commercially available assay (Cusabio, Newark, Delaware). 25 Data were log transformed before analysis and are presented as geometric means and confidence intervals.
Global Microarray
This methodology is described in Supplementary Methods.
Isolation of Murine Glomeruli and Enrichment of Glomerular ECM
The glomeruli of 18-week-old male and female mice (n=3 in each of four groups) were isolated through the Dynabead-based isolation method. 51 All steps were carried out at 4°C to minimize proteolysis. Pure glomerular isolates from three mouse kidneys were incubated for 30 minutes in extraction buffer (10 mM Tris, 150 mM NaCl, 1% (v/v) Triton X-100, 25 mM EDTA, 25 mg/ml leupeptin, 25 mg/ml aprotinin and 0.5 mM AEBSF) to solubilize cellular proteins, and samples were then centrifuged at 140003 g for 10 minutes to yield fraction 1. The remaining pellet was incubated for 30 minutes in alkaline detergent buffer (20 mM NH 4 OH and 0.5% (v/v) Triton X-100 in PBS) to further solubilize cellular proteins and to disrupt cell-ECM interactions. Samples were then centrifuged at 140003 g for 10 minutes to yield fraction 2. The remaining pellet was incubated for 30 minutes in a deoxyribonuclease (DNase) buffer (10 mg/ml DNase I (Roche, Burgess Hill, UK) in PBS) to degrade DNA. The sample was centrifuged at 140003 g for 10 minutes to yield fraction 3, and the final pellet was re-suspended in reducing sample buffer (50 mM Tris-HCl, pH 6.8, 10% (w/v) glycerol, 4% (w/v) sodium dodecylsulfate (SDS), 0.004% (w/v) bromophenol blue, 8% (v/v) b-mercaptoethanol) to yield the ECM fraction. Samples were heat denatured at 70°C for 20 minutes.
Western Blotting
qRT-PCR
MS Data Acquisition
Protein samples were resolved by SDS-PAGE and visualized by Coomassie staining. Gel lanes were sliced and subjected to in-gel trypsin digestion as described previously. 52 Liquid chromatographytandem MS analysis was performed using a nanoACQUITY (C) Quantification of sub-podocyte GBM expansions. (F) Representative images of GBM splitting (arrows) in FVB female mice (TEM images). GBM, glomerular BM. *P,0.05; ****P,0.001, n=15 glomeruli from n=3 mice. (G) 3D model of B6 and FVB GBMs (blue) and splits within the GBM (red). Splits are closely associated with areas of expansion in FVB mice. Scale bars represent 500 nm. F, female; M, male; E, endothelial cells; P, podocytes. UltraPerformance liquid chromatography system (Waters, Elstree, UK) coupled offline to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific). Desalted peptides were separated on a bridged ethyl hybrid C18 analytical column (250 mm length, 75 mm inner diameter, 1.7 mm particle size, 130 Å pore size; Waters) using a 45-min linear gradient from 1% to 25% (v/v) acetonitrile in 0.1% (v/v) formic acid at a flow rate of 200 nl/min. Peptides were selected for fragmentation automatically by data-dependent analysis.
MS Data Analysis and Data Deposition
Tandem mass spectra were extracted using extract_msn (Thermo Fisher Scientific) executed in Mascot Daemon (version 2.2.2; Matrix Science, London, UK). Peak list files were searched against a modified version of the Uniprot mouse database (version 3.70; release date, May 3, 2011), containing ten additional contaminant and reagent sequences of non-mouse origin, using Mascot (version 2.2.06; Matrix Science). 53 Carbamidomethylation of cysteine was set as a fixed modification; oxidation of methionine and hydroxylation of proline and lysine were allowed as variable modifications. Only tryptic peptides were considered, with up to one missed cleavage permitted. Monoisotopic precursor mass values were used, and only doubly and triply charged precursor ions were considered. Mass tolerances for precursor and fragment ions were 0.4 Da and 0.5 Da, respectively. MS datasets were validated using rigorous statistical algorithms at both the peptide and protein level 54, 55 implemented in Scaffold (version 3.6.5; Proteome Software, Portland, Oregon). Protein identifications were accepted upon assignment of at least two unique validated peptides with $90% probability, resulting in $99% probability at the protein level. These acceptance criteria resulted in an estimated protein false discovery rate of 0.1% for all datasets. MS data have been deposited to the ProteomeXchange Consortium (http://www.proteomexchange. org) with the dataset identifier PDX000811 and DOI 10.6019/ PXD000811.
Bioinformatic Analyses
Immunohistochemistry and Image Analysis
Formalin-fixed, paraffin-embedded tissue blocks were sectioned at 5 mm. Sections were dewaxed and treated with recombinant proteinase K (Roche Diagnostics, Indianapolis, IN) for 15 minutes. Sections were blocked with 5% (v/v) donkey serum (Sigma-Aldrich) and 1.5% (v/v) BSA (Sigma-Aldrich) for 30 minutes and with primary antibodies overnight at 4°C. Sections were washed three times with PBS, incubated with secondary antibodies, mounted with polyvinyl alcohol mounting medium (Fluka 10981; Sigma-Aldrich) and imaged using Delta Vision (Applied Precision) restoration microscope using a 603 objective. The images were collected using a Coolsnap HQ (Photometrics) camera with a Z optical spacing of 0.2 mm. Raw images were then deconvolved using the Softworx software and projections of these deconvolved images are shown in the results. Images were also collected using a 203 objective and 3D Histech Pannoramic 250 Flash slide scanner. Images were processed and analyzed using Fiji/ImageJ software (version 1.46r; National Institutes of Health, Bethesda, MD) and Pannoramic Viewer (http://www.3dhistech.com/). Raw images were subjected to signal rescaling using linear transformation for display in the figures. For calculation of mean pixel intensity, a region of interest was drawn around glomeruli and the mean pixel intensity in the selected region measured. This was performed on secondary only controls and on the test samples. The signal from secondary only control samples was subtracted from test samples. Mean pixel intensity measurements were acquired from .60 glomeruli per biologic replicate.
Electron Microscopy
We used TEM and SBF-SEM to investigate glomerular ultrastructure. Tissue samples were fixed for at least 1 hour in a mix of 2% formaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). The samples were post-fixed with reduced osmium (1% OsO 4 and 1.5% K 4 Fe(CN) 6 ) for 1 hour, then with 1% tannic acid in 0.1 M sodium cacodylate buffer for 1 hour, and finally with 1% uranyl acetate in water overnight. The specimens were dehydrated with alcohols, infiltrated with TAAB LV resin and polymerized for 12 hours at 60°C. Ultrathin 70-nm sections were cut with a Leica Ultracut S ultramicrotome and placed on formvar/carbon-coated slot grids. The grids were observed in a Tecnai 12 Biotwin transmission electron microscope at 80 kV. EMdata were screened for ECM characteristics between using Fiji/ ImageJ software (version 1.46r; National Institutes of Health). GBM thickness was quantified in five regions per observation and reported as mean values. For SBF-SEM the polymerized samples were trimmed, glued to aluminum pins and sputter coated with gold/palladium (60 seconds at standard settings). Automated sectioning (60 nm) was completed in a Gatan 3View. The images were taken with FEI Quanta 250 FEG SEM at 3.8 kV accelerating voltage and 0.4 Torr chamber pressure with a pixel size of 12 nm. Models were generated from SBF-SEM using IMOD 3Dmod software developed by David Mastronade and co-workers at the Boulder Laboratory for three-dimensional electron microscopy, which can be downloaded from http://bio3d.colorado.edu/ imod/download.html.
Mouse Strain SNP Analysis
The Jackson laboratory phenome resource was used in order to screen for small nucleotide polymorphisms (SNPs) in ECM proteins identified in this study, and transcripts identified by whole glomerular microarray. The SNP/genotype variation query tool (http://phenome. jax.org/) was used with the following criteria: Choose data sets, strains and filtering options, C57BL/6J, FVB/NJ, polymorphism between certain strains, all examined calls must be nonblank. We screened genes encoding ECM proteins identified by MS in this study, transcripts identified by whole glomerular microarray in addition to genes associated with glomerular disease.
Statistical Analysis
All measurements are shown as mean6SEM. Box plots indicate 25th and 75th percentiles (lower and upper bounds, respectively), 1.53interquar-tile range (whiskers) and median (black line). Bar chart error bars represent standard error of the mean. Analysis of thickness of GBM, podocyte foot process width and frequency of GBM sub-podocyte expansions were compared using one-way analysis of variance with post hoc Bonferroni correction. Numbers of protein-protein interactions and normalized fluorescence intensity were compared using Kruskal-Wallis one-way analysis of variance tests with post hoc Bonferroni correction. 
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